Literature DB >> 30712983

[An unusual case of olmesartan induced enteropathy].

Paulina Henry1, Hélène Dano2, Hubert Piessevaux3, Anne Jouret-Mourin2.   

Abstract

Olmesartan induced enteropathy was first described in 2012. It is a rare adverse effect of this antihypertensive drug. The clinical presentation commonly includes severe chronic diarrhea leading to weight loss and a variable degree of dehydration. Histological findings are most commonly observed in the duodenum and consist of partial or total villous atrophy, increased intraepithelial lymphocytes and inflammation in the lamina propria. Involvement of gastric and colic mucosa has also been described. We report on the case of a 63-year-old man, treated by olmesartan, who presented with severe chronic diarrhea. Biopsies from different levels of the gastrointestinal tract revealed a pandigestive intraepithelial lymphocytosis.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Atrophie villositaire; Enteropathy; Entéropathie; Hyperlymphocytose intraépithéliale pandigestive; Olmesartan; Panlymphocytosis; Villous atrophy

Mesh:

Substances:

Year:  2019        PMID: 30712983     DOI: 10.1016/j.annpat.2018.10.007

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  1 in total

1.  Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.

Authors:  Andromachi Makri; Matilda Florentin; Moses S Elisaf; George Liamis
Journal:  Curr Drug Saf       Date:  2019
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.